159 related articles for article (PubMed ID: 20517234)
81. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.
Schwarz RE
J Clin Oncol; 2001 Mar; 19(6):1879-80. PubMed ID: 11251020
[No Abstract] [Full Text] [Related]
82. [The impact of early gastric cancer diagnosis on indices of survival in patients after radical surgical intervention].
Baĭramov RB; Abdullaeva RT
Klin Khir; 2013 Jun; (6):18-21. PubMed ID: 23987024
[TBL] [Abstract][Full Text] [Related]
83. Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC).
Voron T; Romain B; Bergeat D; Véziant J; Gagnière J; Le Roy B; Pasquer A; Eveno C; Gaujoux S; Pezet D; Gronnier C; ;
J Visc Surg; 2020 Apr; 157(2):117-126. PubMed ID: 32151595
[TBL] [Abstract][Full Text] [Related]
84. [Expanded D2 lymphodissection in combined treatment of gastric cancer: unification of treatment approaches].
Komissarov AV; Vazhenin AV; Privalov AV; Nadvikova EA; Semikopov KV; Maslov VG; Akhmetov IR
Vestn Khir Im I I Grek; 2007; 166(2):27-30. PubMed ID: 17665570
[TBL] [Abstract][Full Text] [Related]
85. [Effect of neoadjuvant chemotherapy on the postoperative pulmonary infection of patients with advanced gastric cancer].
Fan CG; Li GL
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):503-5. PubMed ID: 21792758
[TBL] [Abstract][Full Text] [Related]
86. Comparison of modified D2 lymphadenectomy versus standard D2 lymphadenectomy in total gastrectomy for gastric cancer patients with lymph nodes involvement.
Yang K; Zhang WH; Chen XZ; Hu JK
Surgery; 2015 Nov; 158(5):1446-7. PubMed ID: 25892684
[No Abstract] [Full Text] [Related]
87. Demographic disparities in patterns of care and survival outcomes for patients with resected gastric adenocarcinoma.
Stessin AM; Sherr DL
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):223-33. PubMed ID: 21300617
[TBL] [Abstract][Full Text] [Related]
88. Radical surgery for gastric carcinoma: it is not an issue of whether to perform D1 or D2. Dissect as many lymph nodes as possible and you will be rewarded.
Kodera E; Fujiwara M; Ito Y; Ohashi N; Nakayama G; Koike M; Nakao A
Acta Chir Belg; 2009; 109(1):27-35. PubMed ID: 19341192
[TBL] [Abstract][Full Text] [Related]
89. Perioperative chemotherapy in locally advanced gastric cancer.
Batista TP; Santos CA; Almeida GF
Arq Gastroenterol; 2013; 50(3):236-42. PubMed ID: 24322198
[TBL] [Abstract][Full Text] [Related]
90. [D2 pancreas-preserving lymphadenectomy in tumors of the upper third of the stomach].
Liotta G; Federici O
Tumori; 2003; 89(4 Suppl):67-9. PubMed ID: 12903552
[TBL] [Abstract][Full Text] [Related]
91. Assessment of the value of adjuvant radiotherapy for treatment of gastric adenocarcinoma based on pattern of post-surgical progression.
Wang P; Zhou H; Han G; Ni Q; Dai S; Huang J; Dai C; Yu L
World J Surg Oncol; 2021 Jul; 19(1):205. PubMed ID: 34238296
[TBL] [Abstract][Full Text] [Related]
92. D1 versus D2 lymphadenectomy for gastric cancer.
Schmidt B; Yoon SS
J Surg Oncol; 2013 Mar; 107(3):259-64. PubMed ID: 22513454
[TBL] [Abstract][Full Text] [Related]
93. Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.
Giuliani A; Miccini M; Basso L
World J Gastroenterol; 2014 Apr; 20(14):3889-904. PubMed ID: 24744579
[TBL] [Abstract][Full Text] [Related]
94. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.
Van Cutsem E; Dicato M; Arber N; Benson A; Cunningham D; Diaz-Rubio E; Glimelius B; Goldberg R; Haller D; Haustermans K; Koo-Kang Y; Labianca R; Lang I; Minsky B; Nordlinger B; Roth A; Rougier P; Schmoll HJ; Sobrero A; Tabernero J; Szawlowski A; van de Velde C
Ann Oncol; 2006 Jun; 17 Suppl 6():vi13-8. PubMed ID: 16809641
[No Abstract] [Full Text] [Related]
95. Postoperative chemoradiotherapy after curative gastrectomy for cancer.
Bozzetti F
Ann Oncol; 2004 Feb; 15(2):356. PubMed ID: 14760136
[No Abstract] [Full Text] [Related]
96. Progress of preoperative and postoperative radiotherapy in gastric cancer.
Zhang N; Fei Q; Gu J; Yin L; He X
World J Surg Oncol; 2018 Sep; 16(1):187. PubMed ID: 30213266
[TBL] [Abstract][Full Text] [Related]
97. [FEATURES OF LYMPHADENECTOMY PERFORMANCE IN PATIENTS WITH STOMACH CANCER IN RADICAL SURGERY IN CASE OF VARIANT STRUCTURE OF CELIAC TRUNK].
Sedov VM; Danilov IN; Yaitskiy AN; Zakharenko AA; Vovin KN; Bykova AL
Vestn Khir Im I I Grek; 2015; 174(4):18-23. PubMed ID: 26601512
[TBL] [Abstract][Full Text] [Related]
98. Successfully treated carcinoma erysipeloides from gastric cancer.
Ikeda Y; Niimi M; Takami H; Kodaira S
Ann Oncol; 2003 Aug; 14(8):1328-9. PubMed ID: 12881400
[No Abstract] [Full Text] [Related]
99. Challenges with demographic disparities in gastric cancer care and survival: spectral rather than black and white.
Schwarz RE
Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):221-2. PubMed ID: 21300616
[No Abstract] [Full Text] [Related]
100. The Road to Modified D2 Gastrectomy.
Avital S; Shpitz B
Isr Med Assoc J; 2015 Dec; 17(12):768-9. PubMed ID: 26897980
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
